| 000 | 01537 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514075933.0 | ||
| 264 | 0 | _c20040121 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 024 | 7 |
_a10.1182/blood-2002-11-3624 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGomez, Gregorio | |
| 245 | 0 | 0 |
_aDifferential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. _h[electronic resource] |
| 260 |
_bBlood _cDec 2003 |
||
| 300 |
_a4472-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xdrug therapy |
| 650 | 0 | 4 |
_aConcanavalin A _xtoxicity |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEndotoxemia _xdrug therapy |
| 650 | 0 | 4 |
_aHepatocytes _xdrug effects |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aInosine _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aReceptor, Adenosine A2A _xdeficiency |
| 650 | 0 | 4 |
_aReceptor, Adenosine A3 _xdeficiency |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
| 700 | 1 | _aSitkovsky, Michail V | |
| 773 | 0 |
_tBlood _gvol. 102 _gno. 13 _gp. 4472-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2002-11-3624 _zAvailable from publisher's website |
| 999 |
_c12716907 _d12716907 |
||